Skip to content

Diabetes trial detected better physical quality-of-life scores with liraglutide after one year

No group differences were detected in general well-being or mental quality of life. The physical-score comparison favored liraglutide at the first yearly assessment.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Liraglutide added to metformin produced better physical quality-of-life scores than the other tested medicines at the first yearly assessment. Later comparisons were not statistically significant, leaving uncertainty about whether a difference persisted. No group differences were detected in general well-being or mental quality of life; those findings do not establish that treatments were equivalent.

Keep in mind

In this abstract-based explanation, missing effect sizes and confidence intervals limit judging how noticeable the physical-score difference was or how uncertain later comparisons were.

THE NUMBERS, WITH CONTEXT

What researchers found

Statistically significant improvement at year 1

SF-36 physical component score

Liraglutide versus glargine, glimepiride and sitagliptin, each added to metformin. Differences were not statistically significant at years 2 and 3; that does not show the effect ended.

Diabetes Care, 2024 · Original source ↓

What the questionnaires measured

Researchers assessed general well-being alongside physical and mental quality of life. They reported no detected worsening of health-related quality of life with any medicine, while results differed across questionnaire measures.

Weight and subgroup findings

Greater weight loss helped explain the early physical-score improvement versus glargine and glimepiride. Liraglutide participants with the highest starting body mass index showed the largest gains, a subgroup finding that cannot establish benefits for everyone.

CHECK THE ORIGINAL

The original publication

Impact of Glucose-Lowering Medications on Health-Related Quality of Life in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).

Cherrington AL, Tripputi MT, Younes N et al.
Diabetes Care · 2024

PubMed ID
38190625
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.